来自官方财务报表的收入、利润与现金流历史。
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling test for tumor tissue that provides genomic, transcriptomic, and epigenomic insights.
| 利润表 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 总收入 | $1.2B | $982M | $739M | $564M | $450M | $374M | $287M | $214M | $91M | $50M | $25M |
| 毛利 | $770M | $633M | $449M | $337M | $293M | $251M | $194M | $144M | $47M | $18M | $3M |
| 毛利率% | 65.1% | 64.5% | 60.8% | 59.7% | 65.2% | 67.1% | 67.7% | 67.0% | 52.3% | 36.6% | 12.4% |
| 营业利润（EBIT） | ($470M) | ($436M) | ($444M) | ($565M) | ($544M) | ($411M) | ($255M) | ($82M) | ($93M) | ($77M) | ($44M) |
| 营业利润率% | -39.7% | -44.4% | -60.0% | -100.1% | -121.1% | -110.0% | -88.9% | -38.4% | -102.5% | -153.7% | -173.7% |
| 净利 | ($453M) | ($416M) | ($436M) | ($479M) | ($655M) | ($406M) | ($254M) | ($76M) | ($85M) | ($83M) | ($46M) |
| 净利润率 % | -38.3% | -42.4% | -59.1% | -85.0% | -145.6% | -108.6% | -88.5% | -35.3% | -93.8% | -167.0% | -182.7% |
| EBITDA | — | ($374M) | ($390M) | ($433M) | ($615M) | ($360M) | ($225M) | ($55M) | ($76M) | ($75M) | ($39M) |
| 每股收益（EPS） | $-3.49 | $-3.32 | $-3.56 | $-4.28 | $-6.41 | $-4.00 | $-2.60 | $-0.84 | $-1.00 | $-1.18 | $-3.49 |
| 已发行股数 (M) | — | 125M | 123M | 112M | 102M | 101M | 98M | 91M | 85M | 71M | 13M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 GH 交互式查看器。 /companies/us/GH
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms